this report is the type that transfers wealth from the impatient to the patient.i've researched all of the directors; they're A-grade with a lot of runs on the board, but they're dropping the ball here with investor relations. i wonder why?
i was planning to invest based on this report, but won't as many unaddressed questions i have, & i want to buy into an uptrend; i don't think this report is the catalyst, so will wait for next update/announcement, & there's a change in sentiment, uptrend.
good luck holders.
